The human acute monocytic leukemia cell line
THP-1 (ATCC: TIB-202
TM) and human LUAD cell lines
HCC827 (ATCC: CRL-2868
TM) and A549 (ATCC: CCL-185
TM) were acquired from American Type Culture Collection (ATCC).
THP-1 and
HCC827 were cultured in
RPMI 1640 (Gibco, Carlsbad, CA, USA), and A549 was cultured in
DMEM/F12 (Gibco, Carlsbad, CA, USA). All cell lines were cultured in a medium supplemented with 10% fetal bovine serum (
FBS, Gibco, Carlsbad, CA, USA) and 1% penicillin/streptomycin solution, and maintained at 37 °C with 5% CO
2. These three cell lines were confirmed to be mycoplasma free and were passaged < 10 times after the initial recovery of the frozen stocks. All cell lines were authenticated by performing short tandem repeat profiling before use.
Human
TIAM2 complement DNA (cDNA) expression vector was constructed by Public Protein/Plasmid Library (Nanjing, China) with
pLVX-EF1alpha-IRES-Puro (catalog no. 631988; Clontech, Mountain View, CA, USA).
The
shRNA vectors specifically targeting
TIAM2 (sh
TIAM2#1: 5′-GTTAAGGTGATTCGTTCTATT-3′; sh
TIAM2#2: 5′-GCCCTACTAAAGACATCGAAA-3′) and a scramble control vector (
shGFP: 5′-GCAAGCTGACCCTGAAGTTCA-3′) were purchased from Genechem (Shanghai, China). All the plasmid vectors were verified by performing sequencing [84 (
link)].
Liang L., He H., Jiang S., Liu Y., Huang J., Sun X., Li Y., Jiang Y, & Cong L. (2022). TIAM2 Contributes to Osimertinib Resistance, Cell Motility, and Tumor-Associated Macrophage M2-like Polarization in Lung Adenocarcinoma. International Journal of Molecular Sciences, 23(18), 10415.